Halozyme Therapeutics
$5.44 B
Share price
Change (1 day)
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: $5.44 Billion

As of May 2024 Halozyme Therapeutics has a market cap of $5.44 Billion. This makes Halozyme Therapeutics the world's 2506th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024$5.44 B11.47%
2023$4.88 B-36.54%
2022$7.69 B35.9%
2021$5.66 B-1.95%
2020$5.77 B138.2%
2019$2.42 B14.48%
2018$2.11 B-26.59%
2017$2.88 B125.44%
2016$1.27 B-42.39%
2015$2.22 B83.06%
2014$1.21 B-29.34%
2013$1.71 B127.01%
2012$0.75 B-23.31%
2011$0.98 B23.79%
2010$0.79 B48.02%
2009$0.53 B18%
2008$0.45 B-17.66%
2007$0.55 B0.1%
2006$0.55 B404.64%
2005$0.10 B1.3%
2004$0.10 B

End of Day market cap according to different sources

On May 29th, 2024 the market cap of Halozyme Therapeutics was reported to be:

$5.44 Billion
by Yahoo Finance info icon info icon
$5.44 Billion
by CompaniesMarketCap info icon info icon
$5.44 Billion
by Nasdaq info icon info icon
$5.44 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$347.62 B 6,287.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$157.64 B 2,796.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$771.28 B 14,072.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$120.25 B 2,109.72%๐Ÿ‡ซ๐Ÿ‡ท France
$16.91 B 210.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.23 B-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA